Pasini, Luigi
Pasini, Luigi
A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy
2018-01-01 Sidarovich, V.; De Mariano, M.; Aveic, S.; Pancher, M.; Adami, V.; Gatto, P.; Pizzini, S.; Pasini, L.; Croce, M.; Parodi, F.; Cimmino, F.; Avitabile, M.; Emionite, L.; Cilli, M.; Ferrini, S.; Pagano, A.; Capasso, M.; Quattrone, A.; Tonini, G. P.; Longo, L.
AURA 2: Empowering the discovery of post-transcriptional networks.
2014-01-01 Dassi, Erik; Re, Angela; Leo, Sara; Tebaldi, Toma; Pasini, Luigi; Peroni, Daniele; Quattrone, Alessandro
Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients.
2014-01-01 Boi, S.; Tebaldi, Toma; Re, Angela; Cantaloni, Chiara; Adami, Valentina; Barbareschi, M.; Cristofolini, Marco; Pasini, Luigi; Quattrone, Alessandro
Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA
2021-01-01 Pasini, L.; Notarangelo, M.; Vagheggini, A.; Burgio, M. A.; Crino, L.; Chiadini, E.; Prochowski, A. I.; Delmonte, A.; Ulivi, P.; D'Agostino, V. G.